Max Mano - Department of Medical Oncology, Cliniques Universitaires Saint Luc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 137 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PO2-16-07: Real-world Eligibility for Adjuvant CDK4/6 Inhibitors among Patients Without Genomic Risk for Chemotherapy: a GBECAM Multicenter Retrospective Study

Leandro Oliveira, Thais Megid,Daniela Rosa,Daniele Assad-Suzuki,Daniel Argolo,Solange Sanches,Laura Testa,José Bines,Rafael Kaliks,Débora Gagliato,Romualdo Barroso-Sousa,Tatiana Correa,Andrea Shimada, Daniel Batista,Daniel Musse,Marcelle Cesca,Débora Gaudêncio, Larissa Moura, Julio Araujo,Renata Colombo Bonadio,Artur Katz,Max Mano

Cancer Research（2024）

Cited0Views0Bibtex

Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads

Mariana Ribeiro Monteiro, Natalia Cristina Cardoso Nunes, Aumilto Augusto da Silva Junior, Angelo Bezerra de Souza Fede,Gustavo de Oliveira Bretas, Cristiano de Padua Souza,Max Mano,Jesse Lopes da Silva

Breast Cancer Targets and Therapy (2024): 51-70

Cited2Views0WOSBibtex

Abstract GS03-12: Phase III Study of Adjuvant Ado-Trastuzumab Emtansine Vs Trastuzumab for Residual Invasive HER2-positive Early Breast Cancer after Neoadjuvant Chemotherapy and HER2-targeted Therapy: KATHERINE Final IDFS and Updated OS Analysis

Sibylle Loibl,Max Mano,Michael Untch,Chiun-Shen Huang,Eleftherios Mamounas,Norman Wolmark,Adam Knott,Asna Siddiqui,Thomas Boulet,Beatrice Nyawira,Eleonora Restuccia,Charles Geyer

Cancer Researchno. 9_Supplement (2024): GS03-12

Cited2Views0Bibtex

Brazilian Real-world Data of HR+HER2-early-stage Breast Cancer (BC) Patients Are Poor when Compared to Control Arms of Recent Adjuvant Clinical Trials

Aline Goncalves,Tomas Reinert,Max S. Mano,Heloisa Cruz,Cristiano Resende,Gustavo Bretas,Carlos Barrios,Matheus Costa e Silva,Rafael Paes, Guilherme Silva, Erika Martins, Fernanda Koyama,Bruno Ferrari,Carlos Gil Ferreira, Pedro Aguiar Junior,Rodrigo Dienstmann

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

Phase III Study of Adjuvant Ado-Trastuzumab Emtansine Vs Trastuzumab for Residual Invasive HER2-positive Early Breast Cancer after Neoadjuvant Chemotherapy and HER2-targeted Therapy: KATHERINE Final IDFS and Updated OS Analysis

Michael Untch,Sibylle Loibl,Max S. Mano,Chiun-Sheng Huang,Eleftherios P. Mamounas,Norman Wolmark,Adam Knott,Asna Siddiqui,Thomas Boulet,Beatrice Nyawira,Eleonora Restuccia,Charles E. Geyer

ONCOLOGY RESEARCH AND TREATMENT（2024）

Cited0Views0Bibtex

Physician Leadership in Private Acquisitions: Styles for All Situations

Max S. Mano,Fadil Citaku

Clinics (Sao Paulo, Brazil) (2024): 100443-100443

Cited0Views0WOSBibtex

Abstract PO3-17-11: the Utility of Oncotype DX in Grade 1 Hormone Receptor-Positive Early Breast Cancer: Insights from a Multicentric Real-World Data Study

Renata Colombo Bonadio, Leandro Oliveira, Daniel Batista,Daniela Rosa,Artur Katz,Max Mano,Daniele Assad-Suzuki,Daniel Argolo,Solange Sanches,Rafael Kaliks,Débora Gagliato, Thais Megid,Daniel Musse,Tatiana Correa,Andrea Shimada,Romualdo Barroso-Sousa,Marcelle Cesca,Débora Gaudêncio, Larissa Moura, Julio Araujo,José Bines,Laura Testa

Cancer Researchno. 9_Supplement (2024): PO3-17

Cited0Views0Bibtex

Co-occurrence of Germline Pathogenic Variants in a Brazilian Cohort of Patients with Breast Cancer

Andreza Karine de Barros Almeida Souto,Thaiana Aragao Santana,Leandro Jonata Carvalho Oliveira,Marcela Lima Bulcao,Joao Paulo Gonzaga de Farias,Carolina de Bustamante Fernandes,Fernanda Christtanini Koyama,Daniela Tiaki Uehara,Fernanda Orpinelli Ramos do Rego,Layla Testa Galindo,Bruno Lemos Ferrari,Max S. Mano,Rodrigo Dienstmann,Mariano Zalis,Bernardo Garicochea

Journal of Clinical Oncology（2024）

Cited0Views0Bibtex

Real-World Treatment Patterns and Outcomes in Hormone Receptor Positive HER2 Negative Early-Stage Breast Cancer in a Private Community Oncology Practice of Brazil

Aline Goncalves,Tomas Reinert,Heloisa Cruz, Matheus Silva,Max Mano,Cristiano Resende,Gustavo Bretas, Leandro Oliveira, Maria Cristina Figueroa,Rafael Paes,Jorge Canedo, Fernanda Koyama, Carolina Bueno, Erica Ferreira,Carlos Barrios,Rodrigo Dienstmann

crossref（2024）

Cited0Views0Bibtex

Cancer Outcomes from a Real-World Cohort of Patients Eligible for Adjuvant CDK4/6 Inhibitors but Without Genomic Risk for Chemotherapy: A GBECAM Multicenter Retrospective Study

Leandro Jonata Carvalho Oliveira,Daniela Dornelles Rosa,Artur Katz,Daniele Assad Suzuki,Daniel F. Argolo,Solange Moraes Sanches,Laura Testa,Jose Bines,Rafael Alioska Kaliks,Debora De Melo Gagliato,Romualdo Barroso-Sousa,Tatiana Strava Correa,Andrea Shimada,Daniel Negrini Batista, Daniel Musse Gomes,Marcelle Goldner Cesca, Debora Souza Gaudencio, Julio Antonio Pereira de Araujo,Renata Colombo Bonadio,Max S. Mano

Journal of Clinical Oncologyno. 16_suppl (2024): 540-540

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn